Correlation Between Oramed Pharmaceuticals and Shagrir Group

Can any of the company-specific risk be diversified away by investing in both Oramed Pharmaceuticals and Shagrir Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oramed Pharmaceuticals and Shagrir Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oramed Pharmaceuticals and Shagrir Group Vehicle, you can compare the effects of market volatilities on Oramed Pharmaceuticals and Shagrir Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oramed Pharmaceuticals with a short position of Shagrir Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oramed Pharmaceuticals and Shagrir Group.

Diversification Opportunities for Oramed Pharmaceuticals and Shagrir Group

-0.67

Correlation Coefficient

Oramed Pharmaceuticals  Shagrir Group

Excellent diversification

The 3 months correlation between Oramed and Shagrir is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Oramed Pharmaceuticals and Shagrir Group Vehicle in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shagrir Group Vehicle and Oramed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oramed Pharmaceuticals are associated (or correlated) with Shagrir Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shagrir Group Vehicle has no effect on the direction of Oramed Pharmaceuticals i.e., Oramed Pharmaceuticals and Shagrir Group go up and down completely randomly.

Pair Corralation between Oramed Pharmaceuticals and Shagrir Group

Assuming the 90 days trading horizon Oramed Pharmaceuticals is expected to under-perform the Shagrir Group. In addition to that, Oramed Pharmaceuticals is 1.01 times more volatile than Shagrir Group Vehicle. It trades about -0.1 of its total potential returns per unit of risk. Shagrir Group Vehicle is currently generating about 0.33 per unit of volatility. If you would invest  160,300  in Shagrir Group Vehicle on May 6, 2025 and sell it today you would earn a total of  76,200  from holding Shagrir Group Vehicle or generate 47.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Oramed Pharmaceuticals  vs.  Shagrir Group Vehicle

Oramed Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oramed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Shagrir Group Vehicle

Risk-Adjusted Performance

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Shagrir Group Vehicle are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shagrir Group sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oramed Pharmaceuticals and Shagrir Group

The main advantage of trading using opposite Oramed Pharmaceuticals and Shagrir Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oramed Pharmaceuticals position performs unexpectedly, Shagrir Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shagrir Group will offset losses from the drop in Shagrir Group's long position.

The idea behind Oramed Pharmaceuticals and Shagrir Group Vehicle pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.